肺血栓栓塞症中的IL-33/sST2信号通路:一项临床观察性研究
Metin Yadigaroğlu1, Murat Güzel1, Elif Erdem2
1Samsun University, Faculty of Medicine, Department of Emergency Medicine, Samsun, Turkey.
Cytokine
|July 31, 2024
概括
降低介素-33 (IL-33) 和增加可溶性抑制瘤发生率2 (sST2) 水平是诊断肺血栓栓塞 (PTE) 和预测患者死亡率的有效生物标志物. 这些发现突显了IL-33/sST2通路在PTE中的作用.
科学领域:
- 心血管医学 心血管医学
- 生物标志物发现发现
- 肺栓塞研究研究 肺栓塞研究
背景情况:
- 肺血栓塞栓症 (PTE) 是一种危及生命的心血管紧急情况.
- 介质素-33 (IL-33) /可溶性抑制瘤发生性2 (sST2) 信号通路与心血管风险有关,而sST2升高是已知的因素.
- 了解IL-33/sST2生物标志物在PTE中的作用对于改善患者的治疗结果至关重要.
研究的目的:
- 评估IL-33/sST2通路生物标志物的诊断实用性,用于识别PTE.
- 评估这些生物标志物的有效性,以确定PTE的临床严重程度.
- 研究IL-33/sST2生物标志物的预后价值,用于预测PTE患者的死亡率.
主要方法:
- 一项前性观察性研究与112名PTE患者和62名健康对照进行.
- 在所有参与者中测量IL-33和sST2水平.
- 统计分析,包括接收器操作特征 (ROC) 曲线分析,用于确定生物标志物的诊断和预后有效性.
主要成果:
- 与对照组相比,PTE患者的IL-33水平显著降低,sST2水平较高 (p < 0.001).
- sST2显示了PTE的高诊断准确性 (AUC = 0.818),最佳切断值>14.48 ng/mL.
- IL-33和sST2都是PTE患者死亡率的显著预测因素,AUC值高预测死亡率 (IL-33 AUC = 0.801,sST2 AUC = 0.824).
结论:
- 降低IL-33和增加sST2是诊断PTE的有价值的生物标志物.
- 这些生物标志物有效预测诊断为PTE的患者的死亡风险.
- IL-33/sST2信号通路在PTE的病理生理学和预后中发挥着至关重要的作用.
更多相关视频
07:57Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
Published on: October 25, 2024
282
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
412
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...